- Global Pharma News & Resources

Intradermal Injection Market to achieve CAGR of 10.5% from 2023 to 2032, owing to increasing number of cosmetic surgeries | insightSLICE

The global Intradermal Injection market size was estimated to be US$ 3.3 billion in 2021 and is expected grow at a CAGR of 10.5% between 2023 to 2032.

Intradermal injection is the process of injecting a drug into the skin. Injection methods vary from subcutaneous (just below the skin’s outer surface) to intradermal.

The skin care, hormones, vaccines, and pharmaceuticals can all be administered via intradermal injections. Its potency and absorbability have made it popular among patients requiring smaller doses over time.

Access the sample report:

Market overview:

The global intradermal injection market has experienced significant growth in recent years, especially in emerging markets, due to ease of administration, clinical superiority, and mechanism of action (IGST). B. Scales of diabetes.

Previously used by pharmaceutical companies, metered dose inhalers (MDIs) are now less popular as other mechanisms, such as tablets and syrups, have replaced MDI products.

In addition, new product development, growing awareness of cosmetic surgery, and increasing use of injectables will boost the growth. The rising trend of integrative therapies will also boost the demand for these products.

Reimbursement policies for these procedures would boost demand and sales in many developed countries. Rising prices could lead to stricter emission policies and prescription drug infections by December 2020.

The impact of competition can be seen in the global intradermal injection market. Big companies compete with price cuts, promotions, and special offers to make their brands attractive to consumers.

Augment Therapeutics manufactures high-value pharmaceuticals worldwide that pose a significant threat to North America and Europe intradermal injection companies.

Read more about the report inclusions:

The key players of the Global Intradermal Injection Market are:

Bristol-Myers Squibb Company, BD, OraSure Technologies Inc., West Pharmaceutical Services Inc., Kyoto Chemical Co., Ltd., Terumo Corporation, etc., are some of the major market players operating globally intradermal injection market.

Driving factors for the growth of Global Intradermal Injection Market

The increasing number of cosmetic surgeries and the increasing prevalence of chronic diseases drive the widespread use of intradermal injections. The intradermal injection market is expected to grow faster due to the increasing prevalence of tuberculosis.

According to WHO statistics, tuberculosis is her 13th leading cause of death, with an estimated 10 million new cases each year.

This has led to a dramatic increase in tuberculosis diagnosis rates over the past decade. It is one of the critical factors contributing significantly to the expansion of the tuberculin syringe intradermal injection market.

Cosmetic surgery is also on the rise in North America and Europe. Intradermal vaccination lowers the possible antigen dose, enhances the immune response, and reduces susceptibility to vaccination. In addition, cosmetic procedures dominate topical cosmetic procedures, increasing the demand for intradermal injections.

Global Intradermal Injection Market Key Segments:

By Method:

  • Normal Sized Needles
  • Short Needle
  • Intradermal Microinjection
  • Microneedle Arrays
  • Tattoo Devices
  • Without Needle
  • Intradermal Liquid Jet Devices and
  • Ballistic Intradermal Injectors

By Application:

  • Tuberculin Skin Test
  • Allergy Test
  • Local Aesthetics
  • Others

By End Use:

  • Hospitals
  • Diagnostic Laboratories
  • Academics and Research Institutes
  • Others

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • the United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

The leading market segments of Global Intradermal Injection Market

Companies in the intradermal injection industry use both organic and inorganic methods. Product release and product approval are critical components of the organic initiative. Acquisitions, partnerships, and collaborations are other inorganic growth technologies used in the intradermal injection business.

These expansion plans provide greater geographic reach and commercial opportunities for market players and help drive the overall expansion of the intradermal injection market.

In contrast, needleless are divided into intradermal microinjection, microneedle arrays, and tattoo devices. The hour hands segment is projected to record its highest CAGR between 2023 and 2032, while regular-size hands held the largest market share in 2021.

The tuberculin skin test category is projected to hold the most significant market share in 2021, while the local aesthetics segment will register the highest CAGR throughout the forecast period.

Companies in the intradermal injection industry emphasize implementing product development strategies to meet the changing needs of their customers around the world. This also allows you to maintain your brand identity in the global market.

Intradermal injection treatments and devices have undergone constant innovation over the past few years, and various proprietary technologies are now included in this category to improve the industry.

Finally, the adoption of intradermal injections has increased due to the exponential increase in vaccination and diagnosis rates for various problems over the past decade.

Related reports:

Global Myasthenia Gravis Treatment Market:

Global mHealth Monitoring Diagnostic Medical Devices Market:

Regional performance of Intradermal Injection Market

North America is projected to have the fastest market growth during the forecast due to the presence of local competitors and the high availability and ease of intradermal injections in the region.

North America and Europe are expected to significantly expand the market for these procedures due to improved medical care and government support for intradermal injections. US commercialization of multiple intradermal injections.

The FDA has driven the global demand for intradermal injections. The Asia-Pacific intradermal injection market is expected to grow significantly over the forecast period, owing to improving healthcare costs, increasing investment by market players, and increasing consumer awareness of the benefits of intradermal injections.

Growth Restraining Factors:

Unfavorable government policies hinder market expansion. Despite the benefits demonstrated in several clinical studies, several obstacles stand in the way of using intradermal injections.

Major economies in Europe, the United States, and other developed countries rely on single-dose vaccines and have access to public or private insurance. Multi-dose forms are expected to become more widely available in emerging markets constrained by shipping and availability.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 06-Dec-2022